By providing technology that makes it easier to execute traditionally cumbersome clinical data transfer processes, we enable sites and sponsors to advance clinical trial research more quickly. By doing so, we help accelerate drug development timelines and the pace by which promising discoveries can become new treatments.
Archer’s platform agnostic solution allows sites and sponsors to work efficiently within and between multiple systems, without changing their workflows. The platform was built solely to be a conduit between sites and sponsors and never stores data to minimize security liabilities.
Manual data transcription between source and sponsor is time-consuming, error-prone, and costly, delaying patient access to treatments. Archer ensures integrity, quality, and speed by automating regulatory-grade data collection. Archer decreases data queries by 89% and reduces errors by 99%, eliminating the administrative burden for sites and the operational burden for sponsors.
Keeping up-to-date with IgniteData is easy. Use the sign up box at the bottom of this page to receive our news and blog. If you would like to ask our expert team a question, please contact us.
The founders of IgniteData are Dan Hydes, our CEO, and CTO Richard Yeatman.
IgniteData was formed in 2014 with the aim of helping deliver modern clinical trials; the concept of a cloud-based system that would allow for the interoperability of these siloed healthcare data systems was already embedded in our thinking.